低氧性呼吸衰竭有创通气启动的氧合阈值:两个队列的靶试验模拟
该靶试验模拟纳入MIMIC-IV(2008-2019)和AmsterdamUMCdb(2003-2016)中接受吸入氧浓度≥0.4(经非再呼吸面罩、无创通气或高流量鼻导管)的ICU患者,比较SF<110、<98、<88三个有创通气启动阈值对28天死亡率的影响。主分析(MIMIC-IV,3357例)中,SF<110阈值预测28天有创通气概率72%、死亡率22.2%(CrI 19.2-25.0)最低;SF<98绝对风险增加1.6%(CrI 0.6-2.6),SF<88增加3.5%(CrI 1.4-5.4)。次要分析(AmsterdamUMCdb,1279例)结果相反,SF<110死亡率最高(14.6%,CrI 7.7-22.3),SF<98绝对风险降低0.5%(CrI 0.0-0.9),SF<88降低1.9%(CrI 0.9-2.8)。作者认为效应方向可能取决于基线死亡风险和临床情境。
要点
- 主分析(MIMIC-IV,3357例)中,SF<110阈值预测28天有创通气概率72%、死亡率22.2%(CrI 19.2-25.0),低于SF<98(绝对风险增加1.6%,CrI 0.6-2.6)和SF<88(增加3.5%,CrI 1.4-5.4)。
- 次要分析(AmsterdamUMCdb,1279例)中,SF<110阈值预测死亡率14.6%(CrI 7.7-22.3)最高,SF<98绝对风险降低0.5%(CrI 0.0-0.9),SF<88降低1.9%(CrI 0.9-2.8)。
- 两个队列中,SF<110阈值启动有创通气的预测概率分别为72%(MIMIC-IV)和50%(AmsterdamUMCdb),均高于SF<98(47%和28%)和SF<88(19%和19%)。
- 作者结论:较低低氧血症严重程度时启动有创通气会增加通气率,但可能增加或降低预期死亡率,效应方向可能取决于基线死亡风险和临床情境。
适用人群与场景
- 纳入MIMIC-IV(2008-2019)和AmsterdamUMCdb(2003-2016)数据库中入住ICU、经非再呼吸面罩、无创通气或高流量鼻导管接受吸入氧浓度≥0.4的患者。
诊断标准与关键阈值
- 有创通气启动阈值定义为SF(饱和度-吸入氧浓度比)<110、<98、<88。
研究设计与关键结果
- 靶试验模拟,主分析MIMIC-IV队列3357例,次要分析AmsterdamUMCdb队列1279例;比较SF<110、<98、<88三个有创通气启动阈值对28天死亡率的影响,采用非参数贝叶斯G计算获得后验均值和95%可信区间(CrI)。
- 主分析:SF<110、<98、<88阈值的预测28天有创通气概率分别为72%、47%、19%;SF<110预测28天死亡率22.2%(CrI 19.2-25.0)最低,SF<98绝对风险增加1.6%(CrI 0.6-2.6),SF<88绝对风险增加3.5%(CrI 1.4-5.4)。
- 次要分析:SF<110、<98、<88阈值的预测28天有创通气概率分别为50%、28%、19%;SF<110预测28天死亡率14.6%(CrI 7.7-22.3)最高,SF<98绝对风险降低0.5%(CrI 0.0-0.9),SF<88绝对风险降低1.9%(CrI 0.9-2.8)。
证据类型、等级与局限
- 证据类型:靶试验模拟(target trial emulation),基于两个ICU数据库的观察性数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,较低低氧血症严重程度时启动有创通气会增加有创通气率,但预期死亡率可能增加或降低,效应方向可能取决于基线死亡风险和临床情境。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The optimal thresholds for the initiation of invasive ventilation in patients with hypoxemic respiratory failure are unknown. Using the saturation-to-inspired oxygen ratio (SF), we compared lower versus higher hypoxemia severity thresholds for initiating invasive ventilation.
METHODS: This target trial emulation included patients from the Medical Information Mart for Intensive Care (MIMIC-IV, 2008-2019) and the Amsterdam University Medical Centers (AmsterdamUMCdb, 2003-2016) databases admitted to intensive care and receiving inspired oxygen fraction ≥ 0.4 via non-rebreather mask, noninvasive ventilation, or high-flow nasal cannula. We compared the effect of using invasive ventilation initiation thresholds of SF < 110, < 98, and < 88 on 28-day mortality. MIMIC-IV was used for the primary analysis and AmsterdamUMCdb for the secondary analysis. We obtained posterior means and 95% credible intervals (CrI) with nonparametric Bayesian G-computation.
RESULTS: We studied 3,357 patients in the primary analysis. For invasive ventilation initiation thresholds SF < 110, SF < 98, and SF < 88, the predicted 28-day probabilities of invasive ventilation were 72%, 47%, and 19%. Predicted 28-day mortality was lowest with threshold SF < 110 (22.2%, CrI 19.2 to 25.0), compared to SF < 98 (absolute risk increase 1.6%, CrI 0.6 to 2.6) or SF < 88 (absolute risk increase 3.5%, CrI 1.4 to 5.4). In the secondary analysis (1,279 patients), the predicted 28-day probability of invasive ventilation was 50% for initiation threshold SF < 110, 28% for SF < 98, and 19% for SF < 88. In contrast with the primary analysis, predicted mortality was highest with threshold SF < 110 (14.6%, CrI 7.7 to 22.3), compared to SF < 98 (absolute risk decrease 0.5%, CrI 0.0 to 0.9) or SF < 88 (absolute risk decrease 1.9%, CrI 0.9 to 2.8).
CONCLUSION: Initiating invasive ventilation at lower hypoxemia severity will increase the rate of invasive ventilation, but this can either increase or decrease the expected mortality, with the direction of effect likely depending on baseline mortality risk and clinical context.
参考来源
- Yarnell CJ, Angriman F, Ferreyro BL, et al. Oxygenation thresholds for invasive ventilation in hypoxemic respiratory failure: a target trial emulation in two cohorts. Crit Care. 2023. PMID: 36814287. doi:10.1186/s13054-023-04307-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。